T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited ... M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and ...
18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a strong prognosis predictor for neuroendocrine tumors, according to new research from scientists at the Rigshospitalet, ...
Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...
Insulinoma-Associated Protein 1 (INSM1) is emerging as a significant marker in the diagnosis and characterization of neuroendocrine tumors (NETs ... shown promise in cytology samples of high ...
Median PFS improved from 11.5 months with single-agent everolimus to 29.7 months with the addition of lanreotide. Objective responses occurred about three times as often with the ...
T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited ... M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback